100 related articles for article (PubMed ID: 1300779)
21. DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate.
Toyokuni S; Mori T; Dizdaroglu M
Int J Cancer; 1994 Apr; 57(1):123-8. PubMed ID: 8150530
[TBL] [Abstract][Full Text] [Related]
22. Oxidative renal tubular injuries induced by aminocarboxylate-type iron (III) coordination compounds as candidate renal carcinogens.
Mizuno R; Kawabata T; Sutoh Y; Nishida Y; Okada S
Biometals; 2006 Dec; 19(6):675-83. PubMed ID: 16670936
[TBL] [Abstract][Full Text] [Related]
23. Oxidative damage and cancer.
Oberley TD
Am J Pathol; 2002 Feb; 160(2):403-8. PubMed ID: 11839558
[No Abstract] [Full Text] [Related]
24. Renal cysts and associated renal tumours in male ddY mice injected with ferric nitrilotriacetate.
Kondo A; Deguchi J; Okada S
Virchows Arch; 1995; 427(1):91-9. PubMed ID: 7551351
[TBL] [Abstract][Full Text] [Related]
25. Effects of phlebotomy on the growth of ferric nitrilotriacetate-induced renal cell carcinoma.
Mizote A; Hida AI; Hosako M; Fujisawa M; Kamekawa M; Okada S
Acta Med Okayama; 2002 Aug; 56(4):199-204. PubMed ID: 12199525
[TBL] [Abstract][Full Text] [Related]
26. Deletion and single nucleotide substitution at G:C in the kidney of gpt delta transgenic mice after ferric nitrilotriacetate treatment.
Jiang L; Zhong Y; Akatsuka S; Liu YT; Dutta KK; Lee WH; Onuki J; Masumura K; Nohmi T; Toyokuni S
Cancer Sci; 2006 Nov; 97(11):1159-67. PubMed ID: 16925583
[TBL] [Abstract][Full Text] [Related]
27. A renal carcinogen ferric nitrilotriacetate mediates a temporary accumulation of aldehyde-modified proteins within cytosolic compartment of rat kidney.
Uchida K; Fukuda A; Kawakishi S; Hiai H; Toyokuni S
Arch Biochem Biophys; 1995 Mar; 317(2):405-11. PubMed ID: 7893156
[TBL] [Abstract][Full Text] [Related]
28. Absence of ras mutations and low incidence of p53 mutations in renal cell carcinomas induced by ferric nitrilotriacetate.
Akiyama T; Hamazaki S; Okada S
Jpn J Cancer Res; 1995 Dec; 86(12):1143-9. PubMed ID: 8636002
[TBL] [Abstract][Full Text] [Related]
29. Increased 8-hydroxyguanine levels in DNA and its repair activity in rat kidney after administration of a renal carcinogen, ferric nitrilotriacetate.
Yamaguchi R; Hirano T; Asami S; Chung MH; Sugita A; Kasai H
Carcinogenesis; 1996 Nov; 17(11):2419-22. PubMed ID: 8968057
[TBL] [Abstract][Full Text] [Related]
30. Expression of structure-specific recognition protein mRNA in fetal kidney and Fe-nitrilotriacetate-induced renal carcinoma in the rat.
Xiang YY; Wang DY; Tanaka M; Igarashi H; Naito Y; Ohtawara Y; Shen Q; Sugimura H
Cancer Lett; 1996 Sep; 106(2):271-8. PubMed ID: 8844983
[TBL] [Abstract][Full Text] [Related]
31. Combined histochemical and biochemical analysis of sex hormone dependence of ferric nitrilotriacetate-induced renal lipid peroxidation in ddY mice.
Toyokuni S; Okada S; Hamazaki S; Minamiyama Y; Yamada Y; Liang P; Fukunaga Y; Midorikawa O
Cancer Res; 1990 Sep; 50(17):5574-80. PubMed ID: 2386964
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin.
Toyokuni S; Mori T; Hiai H; Dizdaroglu M
Int J Cancer; 1995 Jul; 62(3):309-13. PubMed ID: 7628872
[TBL] [Abstract][Full Text] [Related]
33. [Pathogenesis and mechanism of iron overload: ferric nitrilotriacetate, hemosiderin, active oxygen, and carcinogenesis].
Awai M
Rinsho Ketsueki; 1989 Aug; 30(8):1115-27. PubMed ID: 2689676
[TBL] [Abstract][Full Text] [Related]
34. Luteolin ameliorates ferric nitrilotriacetic acid induced renal toxicity and tumor promotional response in rat.
Sultana S; Prasad L; Jahangir T
Indian J Exp Biol; 2009 May; 47(5):355-60. PubMed ID: 19579801
[TBL] [Abstract][Full Text] [Related]
35. Translocation of Bax in rat hepatocytes cultured with ferric nitrilotriacetate.
Yajun Z; Hongshan C; Baoxi S; Dengbing Y; Jianhua S; Xinshun G; Li Y; Yi C
Life Sci; 2005 Apr; 76(24):2763-72. PubMed ID: 15808878
[TBL] [Abstract][Full Text] [Related]
36. Alpha-tocopherol induces calnexin in renal tubular cells: another protective mechanism against free radical-induced cellular damage.
Lee WH; Akatsuka S; Shirase T; Dutta KK; Jiang L; Liu YT; Onuki J; Yamada Y; Okawa K; Wada Y; Watanabe A; Kohro T; Noguchi N; Toyokuni S
Arch Biochem Biophys; 2006 Sep; 453(2):168-78. PubMed ID: 16908007
[TBL] [Abstract][Full Text] [Related]
37. MAPKs' status at early stages of renal carcinogenesis and tumors induced by ferric nitrilotriacetate.
Aguilar-Alonso FA; Solano JD; Vargas-Olvera CY; Pacheco-Bernal I; Pariente-Pérez TO; Ibarra-Rubio ME
Mol Cell Biochem; 2015 Jun; 404(1-2):161-70. PubMed ID: 25724684
[TBL] [Abstract][Full Text] [Related]
38. Renoprotective effects of sesamol in ferric nitrilotriacetate-induced oxidative renal injury in rats.
Gupta A; Sharma S; Kaur I; Chopra K
Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):316-21. PubMed ID: 19281599
[TBL] [Abstract][Full Text] [Related]
39. Sex differences in oxidative damage in ddY mouse kidney treated with a renal carcinogen, iron nitrilotriacetate.
Ma Y; Kawabata T; Hamazaki S; Ogino T; Okada S
Carcinogenesis; 1998 Nov; 19(11):1983-8. PubMed ID: 9855013
[TBL] [Abstract][Full Text] [Related]
40. Characterization of N-diethylnitrosamine-initiated and ferric nitrilotriacetate-promoted renal cell carcinoma experimental model and effect of a tamarind seed extract against acute nephrotoxicity and carcinogenesis.
Vargas-Olvera CY; Sánchez-González DJ; Solano JD; Aguilar-Alonso FA; Montalvo-Muñoz F; Martínez-Martínez CM; Medina-Campos ON; Ibarra-Rubio ME
Mol Cell Biochem; 2012 Oct; 369(1-2):105-17. PubMed ID: 22761015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
